Insider · CIK 0001622680
Evan Loh
Files at PRTK (Paratek Pharmaceuticals, Inc.). First filing Nov 1, 2022, latest Dec 22, 2022.
In brief
Evan Loh files SEC Form 4 as CEO and director at PRTK (Paratek Pharmaceuticals, Inc.). Since Nov 1, 2022, Evan Loh has reported 0 open-market buys worth $0 and 3 open-market sells worth $274k, the latest filed on Dec 22, 2022.
A track record needs three past buys with six months of prices behind them; Evan Loh has 0, so none is measured yet.
The newest scored trade: sold $47k of PRTK on Dec 21, 2022, filed Dec 22, 2022, scored 26 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Paratek Pharmaceuticals, Inc. | $47k 23,489 shares | -2% | - | |
| 32Weak | Paratek Pharmaceuticals, Inc. | $196k 99,750 shares | -8% | - | |
| 25Weak | Paratek Pharmaceuticals, Inc. | $31k 8,805 shares | -1% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 20, 2022 | PRTK Paratek Pharmaceuticals, Inc. | AGrant or award Common Stock | +52,500 | $0.00 | $0 | 1,231,687 | Dec 22, 2022 |
| Dec 21, 2022 | PRTK Paratek Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -23,489 | $1.99 | $47k | 1,208,198 | Dec 22, 2022 |
| Dec 12, 2022 | PRTK Paratek Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -37,831 | $1.98 | $75k | 1,241,106 | Dec 14, 2022 |
| Dec 13, 2022 | PRTK Paratek Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -61,919 | $1.96 | $121k | 1,179,187 | Dec 14, 2022 |
| Oct 28, 2022 | PRTK Paratek Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -8,805 | $3.47 | $31k | 1,278,937 | Nov 1, 2022 |
| Oct 25, 2022 | PRTK Paratek Pharmaceuticals, Inc. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 1,287,742 | Oct 27, 2022 |
Questions about Evan Loh
Answered from the filings on this page, as of the latest one.
Is Evan Loh buying or selling?
Not in the last 12 months. Evan Loh's latest open-market trade on SEC Form 4 was sold $47k of PRTK on Dec 21, 2022.
How did Evan Loh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Evan Loh has 0.
Where does Evan Loh file Form 4?
Evan Loh has filed Form 4 at PRTK (Paratek Pharmaceuticals, Inc.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.